Table 2.
Procedural and sedation parameters
| Parameter | n = 66 |
|---|---|
| Procedure type | |
| De novo, n (%) | 51 (77.3) |
| Repeated ablation, n (%) | 15 (12.7) |
| Lab occupancy time, min | 115 [100–140] |
| Skin-to-skin time, min | 75 [60–100] |
| Fluoroscopy time, min | 21 [15–30] |
| Mapping system used, n (%) | 5 (7.6) |
| PFA applications to reach PVI, n | 32 [32–33.5] |
| Time to achieve PVI, min | 25 [22–28] |
| First-pass isolation rate per vein, % | 100 |
| Complications during the procedure, n (%) | 0 |
| Midazolam, mg | 4 ± 0.6 |
| Fentanyl, µg | 116.4 ± 15 |
| Ketamine, mg | 116.1 ± 11 |
| Diastolic PA, mmHg | 76.8 ± 9 |
| Systolic PA, mmHg | 131.7 ± 16 |
| HR, b.p.m. | 74.0 ± 12 |
| Time under sedation, min | 56.4 ± 6 |
| Time taken to sedate the patients adequately and insert the ablation catheter (steps 1 and 2), min | 22.9 ± 3 min |
| Duration of ketamine infusion (step 3), min | 21.8 ± 5 min |
| Time to recover from drug infusion under acceptable sedation (i.e. time from the end of ablation to the achievement of a Ramsey score of 2–3), min | 11.7 ± 3 min |
HR, heart rate; PA, pulmonary artery pressure; PFA, pulsed field ablation; PVI, pulmonary vein isolation.